Regeneron Pharmaceuticals (REGN) EBIT Margin (2009 - 2026)
Regeneron Pharmaceuticals (REGN) posted EBIT Margin of 30.15% for Q2 2026, up 0.78 percentage points from 29.37% a year earlier and up 12.32 percentage points from the prior quarter.
Powered by 
Analysis
Regeneron Pharmaceuticals (REGN) EBIT Margin (2009 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBIT Margin at Regeneron Pharmaceuticals was 24.74%, down 2.28 percentage points year-over-year; for FY2025, it came in at 24.95%, down 3.15 percentage points from FY2024.
- Annual EBIT Margin has declined for four consecutive years, with a five-year change of -17.15 percentage points (FY2020 to FY2025).
- In prior years, Regeneron Pharmaceuticals' EBIT Margin was 28.10% in FY2024 (-2.75 pp), 30.85% in FY2023 (-8.08 pp), 38.93% in FY2022 (-16.74 pp) and 55.67% in FY2021 (+13.58 pp).
- The Q2 2026 figure stands as the highest quarterly EBIT Margin since Q3 2024.
- On a year-over-year basis, EBIT Margin increased in 1 of the last eight quarters, with an average year-over-year change of -2.18 percentage points.
- The strongest year-over-year quarter for EBIT Margin in the past five years was Q3 2021, with a gain of 7.59 percentage points; the weakest was Q2 2022, with a drop of 26.29 percentage points.
- According to Business Quant data, EBIT Margin for the three prior quarters was 17.83% (Q1 2026), 22.65% (Q4 2025) and 27.35% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | 28.37% |
| 10 | Regeneron Pharmaceuticals | 81.27 Bn | 47.47 Bn | 3.71 Bn | 30.15% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 30.15% |
| Mar 31, 2026 | 17.83% |
| Dec 31, 2025 | 22.65% |
| Sep 30, 2025 | 27.35% |
| Jun 30, 2025 | 29.37% |
| Mar 31, 2025 | 19.54% |
| Dec 31, 2024 | 26.13% |
| Sep 30, 2024 | 31.70% |
| Jun 30, 2024 | 30.15% |
| Mar 31, 2024 | 23.89% |
| Dec 31, 2023 | 28.33% |
| Sep 30, 2023 | 33.04% |
| Jun 30, 2023 | 32.19% |
| Mar 31, 2023 | 29.94% |
| Dec 31, 2022 | 33.59% |
| Sep 30, 2022 | 41.68% |
| Jun 30, 2022 | 38.85% |
| Mar 31, 2022 | 42.44% |
| Dec 31, 2021 | 53.31% |
| Sep 30, 2021 | 53.50% |
API Access
Regeneron Pharmaceuticals EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=REGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "REGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=REGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();